KRAS G12C Mutant Solid Tumors
2 clinical trials · Condition
◉ Watch KRAS G12C Mutant Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation (NCT04699188) | Novartis Pharmaceuticals | 2021-02-24 |
Track KRAS G12C Mutant Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.